Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

By Lowe F.C.   McDaniel R.L.   Chmiel J.J.   Hillman A.L.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 477-483

Elsevier

Access to resources Recommend Favorite

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia

By Cowles R.S.   Kabalin J.N.   Childs S.   Lepor H.   Dixon C.   Stein B.   Zabbo A.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Transurethral Resection of the Prostate and Transurethral Microwave Thermotherapy for Treatment of Benign Prostatic Hyperplasia: Two-Year Follow-up

By Waldén Mauritz   Acosta Stefan   Carlsson Per   Pettersson Silas   Dahlstrand Christer  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 3, 1998-06 ,pp. : 204-210

Informa Healthcare

Access to resources Recommend Favorite

Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia

By Kaplan S.A.   Te A.E.  

Urology, Vol. 45, Iss. 4, 1995-04 ,pp. : 566-572

Elsevier

Access to resources Recommend Favorite

Long-term evaluation of Transurethral Needle Ablation of the prostate (TUNA) for treatment of benign prostatic hyperplasia (BPH): clinical outcome after 5 years

By Zlotta A.   Schulman C.   Giannakopoulos X.   Machlum H.   Ostrem E.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 129-129

Elsevier

Access to resources Recommend Favorite